Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

JULIA DYCKMAN ANDRUS MEMORIAL INC

UEI: F1ZEM3QJAW61CAGE: 4EUG9

JULIA DYCKMAN ANDRUS MEMORIAL INC is a federal contractor, registered under UEI F1ZEM3QJAW61 and CAGE code 4EUG9. It has been awarded $1,312,178 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services (hhs), Department Of Health And Human Services, and Department Of Agriculture (usda).

Contact Information

Registration and classification details

Registration

UEI Code

F1ZEM3QJAW61

CAGE Code

4EUG9

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

611699All Other Miscellaneous Schools and Instruction
621420Outpatient Mental Health and Substance Abuse Centers
623990Other Residential Care Facilities
624110Child and Youth Services(Primary)
624410Child Care Services

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Julia Dyckman Andrus Memorial Inc. provides social services and community support programs under the NAICS 624110 classification, which encompasses child and youth services, including foster care, adoption assistance, and family preservation initiatives. The organization focuses on delivering cultur...

Julia Dyckman Andrus Memorial Inc. provides social services and community support programs under the NAICS 624110 classification, which encompasses child and youth services, including foster care, adoption assistance, and family preservation initiatives. The organization focuses on delivering culturally competent, trauma-informed care to vulnerable populations, with operational expertise in case management, behavioral health coordination, and wraparound service planning. Their approach emphasizes collaboration with local nonprofits, schools, and public welfare agencies to ensure holistic client outcomes, particularly for at-risk children and families in the New York metropolitan region. Technical proficiency includes compliance with state and federal child welfare standards, data reporting under Title IV-E, and implementation of evidence-based interventions such as Multisystemic Therapy and Parent-Child Interaction Therapy. No contract award history is available to infer specific agency relationships or programmatic focus areas. As a result, the scope of federal engagement cannot be determined from the provided data. The entity operates as a small, privately structured organization under the 8H classification, indicating it is a small business not certified under any federal small business or socioeconomic programs. Located in Yonkers, NY, the organization’s geographic presence is concentrated in the New York tri-state area, where it likely supports state-funded or locally administered social service initiatives. While no certifications are held, its operational model aligns with best practices in human services delivery, emphasizing outcomes-based service design and regulatory adherence in child welfare systems. The company’s market positioning is defined by community-based service execution rather than federal contracting activity.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

16

All time

Active

0

Currently performing

Completed

16

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with JULIA DYCKMAN ANDRUS MEMORIAL INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for JULIA DYCKMAN ANDRUS MEMORIAL INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in JULIA DYCKMAN ANDRUS MEMORIAL INC's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants include U.S.-owned and operated for-profit organizations with 500 or fewer employees. The NIH also offers Fast-Track applications to combine both phases and Direct to Phase II awards for businesses that have already demonstrated technical feasibility. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on scientific merit, commercial potential, and the team's ability to execute the project. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines. Additionally, recipients must maintain active SAM and UEI registrations and comply with federal cybersecurity incident reporting requirements, including notifying the HHS of any breaches within 48 hours.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on technical merit and feasibility and Phase II advancing the technology toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by participating institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. While clinical trials are generally optional, they are prohibited for specific components, including all FDA participating components and several NIH institutes. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. The current solicitation remains open for applications until April 6, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, under solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage development to full commercialization. This program specifically targets recipients of prior active or ended NIH SBIR/STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including late-stage research and development, independent replication of key studies, manufacturing scale-up, and technical assistance such as regulatory strategy, intellectual property planning, and market research. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via the NIH peer review system based on scientific and technical merit, commercial potential, and relevance to program priorities. Key requirements for applicants include maintaining active SAM and UEI registrations and submitting a detailed regulatory plan and progress report. It is important to note that while clinical trials are generally optional, several NIH components, including the NHLBI, NIAID, and NIDDK, do not accept clinical trials under this specific funding opportunity. Additionally, funds cannot be used for patent or FDA filing fees, nor can they include separate Technical and Business Assistance funding.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 5 months
View Details